It is ubiquitously expressed as a tumor suppressor that antagonizes PI3K signaling pathways and negatively regulates other pathways, such as MAPK (mitogen-activated protein kinase 1), via phosphatase activity involving phosphatidylinositol processing [19]. This evidence concerns the gene MAP2K1 and neoplasm.